Niperotidine
From Infogalactic: the planetary knowledge core
Names | |
---|---|
IUPAC name
(Z)-1-N'-(1,3-benzodioxol-5-ylmethyl)-1-N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine
|
|
Identifiers | |
84845-75-0 | |
ChEMBL | ChEMBL1909284 |
ChemSpider | 11644617 |
EC Number | 284-304-0 |
Jmol 3D model | Interactive image |
KEGG | D07072 |
MeSH | C073716 |
PubChem | 3033952 |
UNII | 12JBD7U72K |
|
|
|
|
Properties | |
C20H26N4O5S | |
Molar mass | 434.50924 g/mol |
Pharmacology | |
ATC code | A02 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
Niperotidine is a histamine antagonist selective for the H2 subtype. It was trialled as a treatment for excessive gastric acidity,[1] but withdrawn after human trials showed liver damage.[2]
References
- ↑ Palasciano G, Maggi V, Portincasa P. The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH-monitoring. Italian Journal of Gastroenterology. 1990 Oct;22(5):291-4. PMID 1983712
- ↑ Gasbarrini G, Gentiloni N, Febbraro S, Gasbarrini A, Di Campli C, Cesana M, Miglio F, Miglioli M, Ghinelli F, D'Ambrosi A, Amoroso P, Pacini F, Salvadori G. Acute liver injury related to the use of niperotidine. Journal of Hepatology. 1997 Sep;27(3):583-6. PMID 9314138
<templatestyles src="Asbox/styles.css"></templatestyles>